Terminology Service < Semantic Lookup Platform

All terms in HP

Label	Id	Description
(4-hydroxyphenyl)pyruvic acid	CHEBI_15999	[An oxo carboxylic acid that is pyruvic acid in which one of the methyl hydrogens is substituted by a 4-hydroxyphenyl group.]
3-(4-hydroxyphenyl)pyruvate	CHEBI_36242	[A 2-oxo monocarboxylic acid anion obtained by removal of a proton from the carboxylic acid group of 3-(4-hydroxyphenyl)pyruvic acid.]
pyruvic acid	CHEBI_32816	[A 2-oxo monocarboxylic acid that is the 2-keto derivative of propionic acid. It is a metabolite obtained during glycolysis.]
Abnormal peripheral nervous system synaptic transmission	HP_0030191	[An anomaly in the communication from a neuron to a target across a synapse in the peripheral nervous system.]
Abnormal facility in opposing the shoulders	HP_0005259
antifungal drug	CHEBI_86327	[Any antifungal agent used to prevent or treat fungal infections in humans or animals.]
antifungal agent	CHEBI_35718	[An antimicrobial agent that destroys fungi by suppressing their ability to grow or reproduce.]
antiinfective agent	CHEBI_35441	[A substance used in the prophylaxis or therapy of infectious diseases.]
Abnormal axial muscle morphology	HP_0040286	[A structural anomaly of the muscles of the trunk and head.]
Absence of pectoralis minor muscle	HP_0005255	[Aplasia (congenital absence) of the pectoralis minor.]
Unilateral absence of pectoralis major muscle	HP_0005256	[Aplasia (congenital absence) of the pectoralis minor on only one side of the chest.]
Pectoralis hypoplasia	HP_0008998	[Underdevelopment of the pectoral muscle.]
Increased anterioposterior diameter of thorax	HP_0005253
Unilateral chest hypoplasia	HP_0005254
prolactin, signal peptide removed form (human)	PR_000048927	[A prolactin (human) that has had the signal peptide removed. UniProtKB:P01236, 29-227.]
prolactin, signal peptide removed form	PR_000021095	[A prolactin that has had the signal peptide removed.]
prolactin (human)	PR_P01236	[A prolactin that is encoded in the genome of human.]
High intestinal obstruction	HP_0005250
leukocyte activation involved in immune response	GO_0002366	[A change in morphology and behavior of a leukocyte resulting from exposure to a specific antigen, mitogen, cytokine, cellular ligand, or soluble factor, leading to the initiation or perpetuation of an immune response.]
cell activation involved in immune response	GO_0002263	[A change in the morphology or behavior of a cell resulting from exposure to an activating factor such as a cellular or soluble ligand, leading to the initiation or perpetuation of an immune response.]